Search results
Results from the WOW.Com Content Network
The management of schizophrenia usually involves many aspects including psychological, pharmacological, social, educational, and employment-related interventions directed to recovery, and reducing the impact of schizophrenia on quality of life, social functioning, and longevity.
The question of how schizophrenia could be primarily genetically influenced, given that people with schizophrenia have lower fertility rates, is a paradox. It is expected that genetic variants that increase the risk of schizophrenia would be selected against, due to their negative effects on reproductive fitness .
Saphris – atypical antipsychotic used to treat schizophrenia and bipolar disorder; Serax – anti-anxiety medication of the benzodiazepine class, often used to help during detoxification from alcohol or other addictive substances; Serentil (mesoridazine) – an antipsychotic drug used in the treatment of schizophrenia [1]
Coordinated Specialty Care (CSC) is a recovery-oriented treatment program designed for people with first episode psychosis (FEP). [1] CSC consists of collaborative treatment planning between the client and the client's care team, consisting of mental health clinicians, psychiatrists, and case managers.
This page was last edited on 28 October 2021, at 20:46 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
German Physician Emil Kraepelin was more interested in the causes of mental disorders and potential classifications rather than focusing on and attempting to treating symptoms of mental disorders. This led to the classification of manic depression and Schizophrenia, as well as the start of a framework for classifying other disorders.
People with schizophrenia are at a higher than average risk of physical ill health, and earlier death than the general population. [1] [2] [3] The fatal conditions include cardiovascular, respiratory and metabolic disorders. [4]
Schizophrenia: An Unfinished History is a 2022 non-fiction book by the practicing psychoanalyst and historian of psychiatry Orna Ophir. The book summarizes the history of the conceptualization, diagnosis, and lived experiences of schizophrenia through the lens of competing views of schizophrenia as a natural, biological construct and as a spectrum of disorders, existing on a continuum of behavior.